Shandong Weigao Group Medical Polymer Company Limited
HKSE: 1066.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Rinan Cong
- Employees
- 12,719
- Headquarters
- Weihai, China
- IPO year
- 2004
- Market cap
- HK$15.6B
- Website
- https://www.weigaogroup.com
Loading 1066…
Loading profile data…Frequently asked questions about 1066
What does Shandong Weigao Group Medical Polymer Company Limited (1066.HK) do?
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments....
Where does 1066.HK trade?
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) trades on the Hong Kong Stock Exchange.
What sector is 1066.HK in?
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Shandong Weigao Group Medical Polymer Company Limited?
Rinan Cong is the chief executive officer of Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Where is Shandong Weigao Group Medical Polymer Company Limited headquartered?
Shandong Weigao Group Medical Polymer Company Limited is headquartered in China.
Does 1066.HK pay a dividend?
Yes — Shandong Weigao Group Medical Polymer Company Limited (1066.HK) paid a trailing twelve-month dividend of HKD 0.24 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1066.HK go public?
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) completed its initial public offering in 2004.